Posts


 |



FDA approves MSD's once-daily HIV combo Idvynso

MSD (Merck & Co) has secured a US approval for its two-drug human immunodeficiency virus ( HIV ) combination ... View article...

How life-saving HIV therapy has contributed to increased rates of a sexually transmitted disease

... antiretroviral therapy (HAART) became widely available—with these increases concentrated among men, while rates among women continued to decline ... View article...

One in three young women in Africa have never tested for HIV – new study shows where the gaps lie

Adolescent girls and young women are at the heart of the HIV epidemic in sub-Saharan Africa. They need to know their HIV status. View article...

For Young People, Now's the Time to Talk About HIV

Despite breakthrough drugs and treatment, adolescents and young adults continue to face higher rates of new HIV /AIDS infections. View article...

Population pharmacokinetics of tenofovir alafenamide delivered via an annual subdermal ...

A diverse portfolio of HIV prevention products likely will be needed to help attain the ambitious targets set by UNAIDS for the global reduction ... View article...

Protect Access to HIV PrEP and Other Preventive Services

PrEP4All urges you to protect preventive care, including HIV PrEP, cancer and diabetes screenings and statins for heart health. Here's how. View article...

Early Immune Response Tied to HIV Antibody Defense

Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune. View article...

Study Predicts HIV Mortality Using Machine Learning

Researchers applied `machine learning` to predict mortality among people living with HIV receiving `antiretroviral therapy` in public health ... View article...